Anne Olson - Jan 1, 2022 Form 4 Insider Report for CENTERSPACE (CSR)

Role
COO, Gen Counsel and Secretary
Signature
Anne Olson
Stock symbol
CSR
Transactions as of
Jan 1, 2022
Transactions value $
$800,033
Form type
4
Date filed
1/4/2022, 05:00 PM
Previous filing
May 28, 2021
Next filing
Jan 31, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSR Common Shares of Beneficial Interest Options Exercise $0 +539 +5.33% $0.00 10.7K Jan 1, 2022 Direct F1
transaction CSR Common Shares of Beneficial Interest Tax liability -$34.5K -311 -2.92% $110.90 10.3K Jan 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSR Restricted Stock Units Award $0 +1.12K $0.00 1.12K Jan 1, 2022 Common Shares of Beneficial Interest 1.12K $0.00 Direct F3
transaction CSR Restricted Stock Units Options Exercise $0 -539 -33.29% $0.00 1.08K Jan 1, 2022 Common Shares of Beneficial Interest 539 $0.00 Direct
transaction CSR Stock Options (Right to Buy) Award $835K +7.53K $110.90 7.53K Jan 1, 2022 Common Shares of Beneficial Interest 7.53K $110.90 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares includes 929 additional shares that were not previously reported due to administrative errors. The majority of these shares are time-vested RSUs that were appropriately reported as derivates on the reporting person's Forms 4 at the time of grant, but not recategorized as shares of common stock at the time of vesting.
F2 Represents shares withheld for payment of taxes in connection with the vesting of restricted stock.
F3 Represents a contingent right to receive 1,121 common shares of beneficial interest of Centerspace vesting over three years, in one-third increments on each anniversary of the grant date: January 1, 2023, 2024 and 2025.
F4 Represents the right to purchase 7,525 common shares of beneficial interest of the Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2023, 2024, 2025 and 2026.